Home / Health / Kids on Weight Drugs Face Nutrient Deficiencies
Kids on Weight Drugs Face Nutrient Deficiencies
27 Sep
Summary
- Nearly one in six children developed a deficiency within a year.
- Vitamin D deficiency affected 12% of young patients.
- Nutritional counseling was given to only 5% of patients initially.
A concerning trend has emerged regarding the use of GLP-1 medications in children, with a new study indicating a heightened risk of nutritional deficiencies. Research published in Childhood Obesity found that approximately 16.8% of young patients experienced a diagnosed deficiency within the first year of treatment.
Vitamin D deficiency was notably prevalent, affecting 12% of these children. Experts suggest that adolescence, a period of rapid growth and development, requires substantial nutritional support, which may be impacted by GLP-1 medications affecting appetite and food intake.
Despite these risks, proactive nutritional support appears insufficient. The study found that only 5% of patients received nutritional counseling within 30 days of starting GLP-1 treatment, and less than 25% received it within six months. This highlights a critical need for integrated nutritional management alongside GLP-1 prescriptions for pediatric patients.
